Compared with the non-DM group, PLA patients with DM had a higher C-reactive protein (CRP, an inflammatory marker)level, higher EMI incidence and longer LOS, which showed that PLA patients with DM have more severe clinical manifestations. The gene discussed is CRP; the disease is diabetes mellitus.